{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:13:04Z","timestamp":1789776784645,"version":"4.0.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10875-024-01752-3","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T07:03:42Z","timestamp":1718780622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["First Report on Chronic Granulomatous Disease from Nepal and a Review of CYBC1 Deficiency"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-5037","authenticated-orcid":false,"given":"Dharmagat","family":"Bhattarai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-4267","authenticated-orcid":false,"given":"Aaqib Zaffar","family":"Banday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phub","family":"Tenzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-6356","authenticated-orcid":false,"given":"Rahila","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-7517","authenticated-orcid":false,"given":"Pratap Kumar","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"1752_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2018.09.019","volume":"143","author":"DC Thomas","year":"2019","unstructured":"Thomas DC, Charbonnier L-M, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, et al. EROS\/CYBC1 mutations: decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143:782\u2013e7851. https:\/\/doi.org\/10.1016\/j.jaci.2018.09.019","journal-title":"J Allergy Clin Immunol"},{"key":"1752_CR2","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1038\/s41467-018-06964-x","volume":"9","author":"GA Arnadottir","year":"2018","unstructured":"Arnadottir GA, Norddahl GL, Gudmundsdottir S, Agustsdottir AB, Sigurdsson S, Jensson BO, et al. A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease. Nat Commun. 2018;9:4447. https:\/\/doi.org\/10.1038\/s41467-018-06964-x","journal-title":"Nat Commun"},{"key":"1752_CR3","doi-asserted-by":"publisher","first-page":"109761","DOI":"10.1016\/j.clim.2023.109761","volume":"255","author":"PM Mortimer","year":"2023","unstructured":"Mortimer PM, Nichols E, Thomas J, Shanbhag R, Singh N, Coomber EL, et al. A novel mutation in EROS (CYBC1) causes chronic granulomatous disease. Clin Immunol. 2023;255:109761. https:\/\/doi.org\/10.1016\/j.clim.2023.109761","journal-title":"Clin Immunol"},{"key":"1752_CR4","doi-asserted-by":"publisher","first-page":"109316","DOI":"10.1016\/j.clim.2023.109316","volume":"251","author":"M Chiriaco","year":"2023","unstructured":"Chiriaco M, De Matteis A, Cifaldi C, Di Matteo G, Rivalta B, Passarelli C, et al. Characterization of AR-CGD female patient with a novel homozygous deletion in CYBC1 gene presenting with unusual clinical phenotype. Clin Immunol. 2023;251:109316. https:\/\/doi.org\/10.1016\/j.clim.2023.109316","journal-title":"Clin Immunol"},{"key":"1752_CR5","doi-asserted-by":"publisher","first-page":"108799","DOI":"10.1016\/j.clim.2021.108799","volume":"229","author":"I Perez-Heras","year":"2021","unstructured":"Perez-Heras I, Tsilifis C, Slatter MA, Brynj\u00f3lfsson SF, Haraldsson \u00c1, Gennery AR. HSCT in two brothers with CGD arising from mutations in CYBC1 corrects the defect in neutrophil function. Clin Immunol. 2021;229:108799. https:\/\/doi.org\/10.1016\/j.clim.2021.108799","journal-title":"Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01752-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01752-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01752-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T09:08:44Z","timestamp":1724058524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01752-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1752"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01752-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest or Competing Interests"}},{"value":"The clinical description of the patient with CYBC1-CGD was presented by the first author (DB) at the ESID 2nd PID Care in Development School in Croatia. The proceedings of the said meeting have not been published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}},{"value":"As this study pertains to anonymous case descriptions and literature review\/analysis of previously published data, ethics approval is not mandated. Informed consent was obtained from patients\/caregivers prior to inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval\/Consent"}}],"article-number":"149"}}